Long-term Registry of Patients Treated With Loncastuximab Tesirine

Withdrawn before enrolling

Conditions studied: B-Cell Lymphomas

In brief

Retrospective and prospective multi-center observational study of patients with B-cell lymphomas treated with loncastuximab tesirine treatment in real-world practice.

Key facts

Study ID

NCT05160064

Run by

ADC Therapeutics S.A.

People needed

0

Starts

2022-06-30

Expected to finish

2025-01-01

Last updated by the study team

2022-06-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be ≥ 18 years of age at the time of consent.
• Initiated or initiating commercially available loncastuximab tesirine treatment.
• Written informed consent must be obtained prior to any registry activities.

You may not qualify if…

• Prior loncastuximab tesirine exposure in clinical trials.

Where it is running

• Compassionate Cancer Care Medical Group — Fountain Valley, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.